Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-cost customized cranioplasty using a 3D digital printing model: a case report.

3D printing in medicine·2018
Same author

Subfascial Gluteal Implant Augmentation.

Clinics in plastic surgery·2018
Same author

PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study.

Immunobiology·2016
Same author

Functional Polymorphism rs13306560 of the MTHFR Gene Is Associated With Essential Hypertension in a Mexican-Mestizo Population.

Circulation. Cardiovascular genetics·2015
Same author

[Tumor necrosis factor alpha (TNF-α) in autoimmune diseases (AIDs): molecular biology and genetics].

Gaceta medica de Mexico·2014
Same author

[Involvement of matrix metalloproteinases in acute coronary syndrome (ACS)].

Gaceta medica de Mexico·2013

Related Experiment Videos

[Molecular bases of heart failure].

José Manuel Rodríguez Pérez1, Guillermo J Gallardo, Gilberto Vargas Alarcón

  • 1Departamento de Fisiologia y Grupo de Estudio en Genómica y Proteómica en Enfermedades Cardiovasculares, Instituto Nacional de Cardiología "Ignacio Chávez".

Archivos De Cardiologia De Mexico
|May 2, 2007
PubMed
Summary

Heart failure (HF) is a complex condition where the body lacks adequate blood supply. Recent research highlights key mechanisms like oxidative stress and mitochondrial dysfunction as triggers for this cardiovascular disease.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Pathophysiology
  • Molecular Biology

Background:

  • Heart failure (HF) is a critical condition characterized by inadequate blood and nutrient delivery to meet tissue demands.
  • HF frequently develops in individuals with pre-existing cardiovascular conditions, including myocardial infarction, atherosclerosis, cardiomyopathy, myocarditis, congenital defects, or valvular disease.

Purpose of the Study:

  • To elucidate the complex pathophysiologic mechanisms underlying heart failure.
  • To identify the key molecular and cellular triggers contributing to the development of heart failure.

Main Methods:

  • Review of recent scientific literature on heart failure etiology and pathogenesis.
  • Analysis of proposed inter-related mechanisms implicated in HF development.

Main Results:

  • Substantial progress has been made in understanding the multifaceted nature of heart failure.
  • Key proposed triggers include oxidative stress, aberrant signal transduction, impaired intracellular calcium handling, mitochondrial dysfunction, and inherited genetic mutations.

Conclusions:

  • Heart failure arises from a complex interplay of underlying cardiovascular diseases and specific molecular triggers.
  • Further research into these mechanisms is crucial for advancing heart failure treatment and prevention strategies.